In summary, we herein reveal that mimetic peptides derived from SDC2 (e.g., S2-FE) can interrupt the interaction of SDC2 with pro-MMP-7 and thus suppress colon cancer cell activities. Here, SDC2 is linked to colonic neoplasm.